ELIS

Direxion Shares ETF Trust Direxion Daily LLY Bear 1X ETF

Positive
Neutral
Negative
Sentiment 3-Months
Positive
Neutral 100%
Negative

Neutral
GlobeNewsWire
11 days ago
Direxion Closing Ten ETFs
New York, New York, March 13, 2026 (GLOBE NEWSWIRE) -- Closures Due to Limited Interest Since Launch Due to their inability to attract sufficient investment assets, the Board of Trustees of the Direxion Shares ETF Trust has decided to liquidate and close ten ETFs (each, a “Fund” and collectively, the “Funds”), based on the recommendation of the Funds' adviser, Rafferty Asset Management, LLC. The Board concluded that liquidating and closing the Funds would be in the best interest of the Funds and their shareholders.
Direxion Closing Ten ETFs
Positive
Benzinga
5 months ago
Healthcare Opportunities And Risks Collide For Direxion's Eli Lilly-Focused ELIL, ELIS ETFs
As the largest publicly traded U.S. healthcare enterprise, Eli Lilly & Co. (NYSE:LLY) has historically offered investors a reliable avenue for growth. Indeed, this narrative has been particularly powerful in 2023 and 2024, which saw LLY stock rise from around $360 to approximately $960 in late summer of last year.
Healthcare Opportunities And Risks Collide For Direxion's Eli Lilly-Focused ELIL, ELIS ETFs
Neutral
ETF Trends
6 months ago
Leveraged ETFs: Single-Stock Surge
2025 has so far been a big year for leveraged ETFs. I wrote a research note on leveraged ETFs earlier this year (read more here) where I discussed some trends in the leveraged ETF market.
Leveraged ETFs: Single-Stock Surge
Neutral
ETF Trends
7 months ago
Are More Challenges Ahead for Eli Lilly After Earnings Beat?
Getting stuck in sideways purgatory can leave traders flummoxed. Should they cut bait or ride out the position in hopes that it will eventually trend upwards?
Are More Challenges Ahead for Eli Lilly After Earnings Beat?
Neutral
ETF Trends
1 year ago
Direxion Debuts New Single-Stock ETFs for Eli Lilly & Palo Alto
On Wednesday, Direxion expanded its suite of leveraged and inverse ETF products with the launch of four new funds.  Each of the new Direxion ETFs offers leveraged or inverse exposure to a single stock's daily price performance.
Direxion Debuts New Single-Stock ETFs for Eli Lilly & Palo Alto